Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
904M |
$1.08M |
$0.00 |
Nov 14, 2024 |
Direct |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
40.4M |
$48.5K |
$0.00 |
Nov 14, 2024 |
By Davis Island Ventures LLC |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
39.8M |
$47.7K |
$0.00 |
Nov 14, 2024 |
By Quest Bio LLC |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
27.8M |
$33.4K |
$0.00 |
Nov 14, 2024 |
By Innovative Lifesci Investments LLC |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
12.5M |
$15K |
$0.00 |
Nov 14, 2024 |
By TT Insurance Investment LLC |
Peak Bio, Inc. |
Director |
Common Stock |
0 |
$0 |
$0.27 |
Nov 14, 2024 |
Direct |
Peak Bio, Inc. |
Director |
Common Stock |
0 |
$0 |
$0.27 |
Nov 14, 2024 |
Indirect |
Monterey Innovation Acquisition Corp |
Director, 10%+ Owner |
Common Stock |
1.42M |
|
|
Mar 9, 2023 |
Indirect |
AtlasClear Holdings, Inc. |
Director |
Warrants |
354K |
|
|
Mar 20, 2024 |
Direct |
AtlasClear Holdings, Inc. |
Director |
Common Stock |
243K |
|
|
Feb 9, 2024 |
Direct |
Monterey Innovation Acquisition Corp |
Director, 10%+ Owner |
Common Stock |
35K |
|
|
Mar 9, 2023 |
Direct |
Peak Bio, Inc. |
Director |
Convertible Notes |
0 |
|
|
Nov 14, 2024 |
Direct |
Peak Bio, Inc. |
Director |
Stock Option (Right to Buy) |
0 |
|
|
Nov 14, 2024 |
Direct |
Quantum FinTech Acquisition Corp |
Director |
Common Stock |
0 |
|
|
Feb 9, 2024 |
Direct |